Callosal microstructural abnormalities in Alzheimer's disease and alcoholism: Same phenotype, different mechanisms

Psychiatry Research - Neuroimaging

Volumn 184, Issue 1, 2010, Pages 49-56

  Pitel, Anne Lise ^a   Chanraud, Sandra ^a,b   Sullivan, Edith V ^a   Pfefferbaum, Adolf ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

Alcoholism; Alzheimer's disease; Corpus callosum; DTI; MRI; Ventricle

Indexed keywords

ADULT; AGED; ALCOHOLISM; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; BRAIN SIZE; BRAIN VENTRICLE; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALCOHOLISM; ALZHEIMER DISEASE; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBRAL VENTRICLES; CORPUS CALLOSUM; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; STATISTICS AS TOPIC;

EID: 77956955564     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.07.006     Document Type: Article

References (51)

1. Bellani M., Yeh P.H., Tansella M., Balestrieri M., Soares J.C., Brambilla P. DTI studies of corpus callosum in bipolar disorder. Biochemical Society Transactions 2009, 37:1096-1098.
2. Chaim T.M., Duran F.L., Uchida R.R., Perico C.A., de Castro C.C., Busatto G.F. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Research 2007, 154:59-68.
3. Chanraud S., Reynaud M., Wessa M., Penttila J., Kostogianni N., Cachia A., Artiges E., Delain F., Perrin M., Aubin H.J., Cointepas Y., Martelli C., Martinot J.L. Diffusion tensor tractography in mesencephalic bundles: relation to mental flexibility in detoxified alcohol-dependent subjects. Neuropsychopharmacology 2009, 34:1223-1232.
4. Cho H., Yang D.W., Shon Y.M., Kim B.S., Kim Y.I., Choi Y.B., Lee K.S., Shim Y.S., Yoon B., Kim W., Ahn K.J. Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. Journal of Korean Medical Science 2008, 23:477-483.
5. Chua T.C., Wen W., Slavin M.J., Sachdev P.S. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Current Opinion in Neurology 2008, 21:83-92.
6. Creasey H., Schwartz M., Frederickson H., Haxby J.V., Rapoport S.I. Quantitative computed tomography in dementia of the Alzheimer type. Neurology 1986, 36:1563-1568.
7. de la Monte S.M. Disproportionate atrophy of cerebral white matter in chronic alcoholics. Archives of Neurology 1988, 45:990-992.
8. DeCarli C., Haxby J.V., Gillette J.A., Teichberg D., Rapoport S.I., Schapiro M.B. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology 1992, 42:2029-2036.
9. Erceg-Hurn D.M., Mirosevich V.M. Modern robust statistical methods: an easy way to maximize the accuracy and power of your research. The American Psychologist 2008, 63:591-601.
10. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
11. Forstl H., Zerfass R., Geiger-Kabisch C., Sattel H., Besthorn C., Hentschel F. Brain atrophy in normal ageing and Alzheimer's disease. Volumetric discrimination and clinical correlations. British Journal of Psychiatry 1995, 167:739-746.
12. Hollingshead A., Redlich F. Social Class and Mental Illness 1958, John Wiley and Sons, New York.
13. Hommer D., Momenan R., Rawlings R., Ragan P., Williams W., Rio D., Eckardt M. Decreased corpus callosum size among alcoholic women. Archives of Neurology 1996, 53:359-363.
14. Keselman H.J., Algina J., Lix L.M., Wilcox R.R., Deering K.N. A generally robust approach for testing hypotheses and setting confidence intervals for effect sizes. Psychological Methods 2008, 13:110-129.
15. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Archives of Neurology 1985, 42:1097-1105.
16. Lewohl J.M., Wang L., Miles M.F., Zhang L., Dodd P.R., Harris R.A. Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcoholism, Clinical and Experimental Research 2000, 24:1873-1882.
17. Li M.D., Burmeister M. New insights into the genetics of addiction. Nature Reviews. Genetics 2009, 10:225-231.
18. Li S., Pu F., Shi F., Xie S., Wang Y., Jiang T. Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry. Acta Radiologica 2008, 49:84-90.
19. Mattis S. Dementia Rating Scale (DRS) Professional Manual 1988, Psychological Assessment Resources, Inc, Odessa, FL.
20. Mayfield R.D., Lewohl J.M., Dodd P.R., Herlihy A., Liu J., Harris R.A. Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. Journal of Neurochemistry 2002, 81:802-813.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
22. Nelson H.E. The National Adult Reading Test (NART) 1982, Nelson Publishing Company, Windsor, Canada.
23. Nestor S.M., Rupsingh R., Borrie M., Smith M., Accomazzi V., Wells J.L., Fogarty J., Bartha R. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 2008, 131:2443-2454.
24. Parente D.B., Gasparetto E.L., da Cruz L.C., Domingues R.C., Baptista A.C., Carvalho A.C., Domingues R.C. Potential role of diffusion tensor MRI in the differential diagnosis of mild cognitive impairment and Alzheimer's disease. American Journal of Roentgenology 2008, 190:1369-1374.
25. Paula-Barbosa M.M., Tavares M.A. Long term alcohol consumption induces microtubular changes in the adult rat cerebellar cortex. Brain Research 1985, 339:195-199.
26. Persson J., Lind J., Larsson A., Ingvar M., Cruts M., Van Broeckhoven C., Adolfsson R., Nilsson L.G., Nyberg L. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?. Neurology 2006, 66:1029-1033.
27. Pfefferbaum A., Sullivan E.V. Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging. Neuropsychopharmacology 2005, 30:423-432.
28. Pfefferbaum A., Lim K.O., Zipursky R.B., Mathalon D.H., Rosenbloom M.J., Lane B., Ha C.N., Sullivan E.V. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcoholism, Clinical and Experimental Research 1992, 16:1078-1089.
29. Pfefferbaum A., Lim K.O., Desmond J.E., Sullivan E.V. Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study. Alcoholism, Clinical and Experimental Research 1996, 20:752-757.
30. Pfefferbaum A., Sullivan E.V., Swan G.E., Carmelli D. Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiology of Aging 2000, 21:63-74.
31. Pfefferbaum A., Sullivan E.V., Carmelli D. Morphological changes in aging brain structures are differentially affected by time-linked environmental influences despite strong genetic stability. Neurobiology of Aging 2004, 25:175-183.
32. Pfefferbaum A., Adalsteinsson E., Sullivan E.V. Dysmorphology and microstructural degradation of the corpus callosum: interaction of age and alcoholism. Neurobiology of Aging 2006, 27:994-1009.
33. Pfefferbaum A., Rosenbloom M.J., Rohlfing T., Adalsteinsson E., Kemper C.A., Deresinski S., Sullivan E.V. Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum. Neuroimage 2006, 33:239-251.
34. Pfefferbaum A., Rosenbloom M.J., Adalsteinsson E., Sullivan E.V. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage. Brain 2007, 130:48-64.
35. Putzke J., De Beun R., Schreiber R., De Vry J., Tolle T.R., Zieglgansberger W., Spanagel R. Long-term alcohol self-administration and alcohol withdrawal differentially modulate microtubule-associated protein 2 (MAP2) gene expression in the rat brain. Brain Research. Molecular Brain Research 1998, 62:196-205.
36. Roosendaal S.D., Geurts J.J., Vrenken H., Hulst H.E., Cover K.S., Castelijns J.A., Pouwels P.J., Barkhof F. Regional DTI differences in multiple sclerosis patients. Neuroimage 2009, 44:1397-1403.
37. Rotarska-Jagiela A., Oertel-Knoechel V., DeMartino F., van de Ven V., Formisano E., Roebroeck A., Rami A., Schoenmeyer R., Haenschel C., Hendler T., Maurer K., Vogeley K., Linden D.E. Anatomical brain connectivity and positive symptoms of schizophrenia: a diffusion tensor imaging study. Psychiatry Research 2009, 174:9-16.
38. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995, 45:883-888.
39. Shuyu L., Fang P., Xiangqi D., Li D., Tianzi J. Shape analysis of the corpus callosum in Alzheimer's disease. Bioinformatics and Biomedical Engineering ICBBE 2007. The 1st International Conference 2007, 1095-1098.
40. Silbert L.C., Quinn J.F., Moore M.M., Corbridge E., Ball M.J., Murdoch G., Sexton G., Kaye J.A. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology 2003, 61:487-492.
41. Sjobeck M., Englund E. Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Neuropathology and Applied Neurobiology 2003, 29:159-169.
42. Stahl R., Dietrich O., Teipel S.J., Hampel H., Reiser M.F., Schoenberg S.O. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007, 243:483-492.
43. Sullivan E.V., Pfefferbaum A., Adalsteinsson E., Swan G.E., Carmelli D. Differential rates of regional brain change in callosal and ventricular size: a 4-year longitudinal MRI study of elderly men. Cerebral Cortex 2002, 12:438-445.
44. Tarnowska-Dziduszko E., Bertrand E., Szpak G.M. Morphological changes in the corpus callosum in chronic alcoholism. Folia Neuropathologica 1995, 33:25-29.
45. Thompson P.M., Moussai J., Zohoori S., Goldkorn A., Khan A.A., Mega M.S., Small G.W., Cummings J.L., Toga A.W. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cerebral Cortex 1998, 8:492-509.
46. Tomaiuolo F., Scapin M., Di Paola M., Le Nezet P., Fadda L., Musicco M., Caltagirone C., Collins D.L. Gross anatomy of the corpus callosum in Alzheimer's disease: regions of degeneration and their neuropsychological correlates. Dementia and Geriatric Cognitive Disorders 2007, 23:96-103.
47. Ukmar M., Makuc E., Onor M.L., Garbin G., Trevisiol M., Cova M.A. Evaluation of white matter damage in patients with Alzheimer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging. La Radiologia Medica 2008, 113:915-922.
48. Wang P.J., Saykin A.J., Flashman L.A., Wishart H.A., Rabin L.A., Santulli R.B., McHugh T.L., MacDonald J.W., Mamourian A.C. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiology of Aging 2006, 27:1613-1617.
49. Wang L., Goldstein F.C., Veledar E., Levey A.I., Lah J.J., Meltzer C.C., Holder C.A., Mao H. Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. American Journal of Neuroradiology 2009, 30:893-899.
50. Wiggins R.C., Gorman A., Rolsten C., Samorajski T., Ballinger W.E., Freund G. Effects of aging and alcohol on the biochemical composition of histologically normal human brain. Metabolic Brain Disease 1988, 3:67-80.
51. Xiang Z., Haroutunian V., Ho L., Purohit D., Pasinetti G.M. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia. Disease Markers 2006, 22:95-102.